Schrödinger to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

NEW YORK–(BUSINESS WIRE)–Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced that members of the management team will participate in a fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference at 2:30 p.m. ET on Tuesday, June 23, 2020.

A live webcast of the presentation can be accessed under “News & Events” in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. A replay of the webcast will be available on Schrödinger’s website for 90 days following the event.

About Schrödinger

Schrödinger’s industry-leading computational platform to accelerate drug discovery and materials design is deployed by leading biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger is also applying its computational platform to a diverse and extensive pipeline of drug discovery programs in collaboration with pharmaceutical companies and has co-founded leading biotech companies. In addition, Schrödinger is using its platform to advance a pipeline of internal, wholly-owned drug discovery programs.

Contacts

Media Contact:
Stephanie Simon

Ten Bridge Communications

[email protected]
617-581-9333

Investor Contact:
Christina Tartaglia

Stern IR, Inc.

[email protected]
212-362-1200